BIO-RAD LABORATORIES INC.

Company Snapshot

Founded: 1952
Entity Type: Public
Employees: 7,700
Region: U.S.
Revenue: $2,566.5 Millions
Revenue Year: 2024
Segment: Life Sciences and Clinical Diagnostics
Headquarter: California, U.S.
Key Geographics: U.S., Europe, Asia, Canada, Latin America

Company Overview

Bio-Rad Laboratories was established in 1952 to develop biochemical and radiochemicals. Bio-Rad Laboratories designs and manufactures a range of diagnostic tools and services for research institutions, hospitals, pharmaceutical and biotechnology companies, and academic institutions. The company operates in two business segments: Life Science and Clinical Diagnostics. The life sciences category’s equipment, systems, reagents, and consumables are used to characterize, quantify, segregate, and purify biological components such as proteins, cells, and nucleic acids. Over 8,000 employees work across the globe. They include degree-holding scientists, engineers, software developers, and other technical support personnel. The company has a large direct sales force for global operations, with over 830 direct sales and sales management employees worldwide.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

BIO-RAD LABORATORIES INC. In Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

According to our Research Report the biochips market report includes global revenue ($ Million) for base year data of 2023 and estimated data for the forecast period 2024 through 2029.

Oncology Diagnostics: Global Markets

BCC Research Report: Dive into oncology diagnostics market revenues can be estimated based on the product category, by application, by end user and by region.

Proteomics: Technologies and Global Markets

According to BCC Research proteomics market includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.

Company's Business Segments

  • Life Sciences : Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes.
  • Clinical Diagnostics : Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.
  • Others : Miscellaneous operations

Applications/End User Industries

  • Academic and Research Institutions
  • Universities
  • Research Centers
  • Academic Laboratories
  • Biotechnology
  • Blood Banks and Transfusion Centers
  • Regulatory Agencies
  • Public Health Organizations
  • Contract Research Organizations
  • Clinical Laboratories
  • Medical Laboratories
  • Diagnostic Centers
  • Physician Office Laboratories
  • Pharmaceuticals